For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit



BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress., T.M. Fernando; R. Marullo; B.Pera Gresely; J.M. Phillip; S.Ning Yang; G. Lundell-Smith; I. Torregroza; H. Ahn; T. Evans; B. Gyorffy; G.G. Prive; M. Hirano; A.M. Melnick; L. Cerchietti, Cancer Discov, 2019 05, 9, 5, p.662-679, (2019) PubMed

Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML., C. Duy; M. Teater; F.E. Garrett-Bakelman; T.C. Lee; C. Meydan; J.L. Glass; M. Li; J.C. Hellmuth; H.P. Mohammad; K.N. Smitheman; A.H. Shih; O. Abdel-Wahab; M.S. Tallman; M.L. Guzman; D. Muench; L. Grimes; G.J. Roboz; R.G. Kruger; C.L. Creasy; E.M. Paietta; R.L. Levine; M. Carroll; A.M. Melnick, Cancer Discov, 2019 07, 9, 7, p.872-889, (2019) PubMed

PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas., M. Pascual; M. Mena-Varas; E.Francisco Robles; M.J. Garcia-Barchino; C. Panizo; S. Hervas-Stubbs; D. Alignani; A. Sagardoy; J.Ignacio Martinez-Ferrandis; K.L. Bunting; S. Meier; X. Sagaert; D. Bagnara; E. Guruceaga; O. Blanco; J. Celay; A. Martínez-Baztan; N. Casares; J.José Lasarte; T. MacCarthy; A. Melnick; J.Angel Martínez-Climent; S. Roa, Blood, 2019 05 30, 133, 22, p.2401-2412, (2019) PubMed

Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response., X. Agirre; C. Meydan; Y. Jiang; L. Garate; A.S. Doane; Z. Li; A. Verma; B. Paiva; J.I. Martín-Subero; O. Elemento; C.E. Mason; F. Prosper; A. Melnick, Nat Commun, 2019 02 18, 10, 1, p.821, (2019) PubMed

Emerging epigenetic-modulating therapies in lymphoma., D. Sermer; L. Pasqualucci; H.G. Wendel; A. Melnick; A. Younes, Nat Rev Clin Oncol, 2019 08, 16, 8, p.494-507, (2019) PubMed

BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection., B. Zhu; R. Zhang; C. Li; L. Jiang; M. Xiang; Z. Ye; H. Kita; A.M. Melnick; A.L. Dent; J. Sun, Proc Natl Acad Sci U S A, 2019 06 11, 116, 24, p.11888-11893, (2019) PubMed

Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition., D. Ennishi; K. Takata; W. Béguelin; G. Duns; A. Mottok; P. Farinha; A. Bashashati; S. Saberi; M. Boyle; B. Meissner; S. Ben-Neriah; B.W. Woolcock; A. Telenius; D. Lai; M. Teater; R. Kridel; K.J. Savage; L.H. Sehn; R.D. Morin; M.A. Marra; S.P. Shah; J.M. Connors; R.D. Gascoyne; D.W. Scott; A.M. Melnick; C. Steidl, Cancer Discov, 2019 04, 9, 4, p.546-563, (2019) PubMed

Role of chromosomal architecture in germinal center B cells and lymphomagenesis., M.A. Rivas; A.M. Melnick, Curr Opin Hematol, 2019 07, 26, 4, p.294-302, (2019) PubMed


Engineering of a Histone-Recognition Domain in Dnmt3a Alters the Epigenetic Landscape and Phenotypic Features of Mouse ESCs., K.M. Noh; H. Wang; H.R. Kim; W. Wenderski; F. Fang; C.H. Li; S. Dewell; S.H. Hughes; A.M. Melnick; D.J. Patel; H. Li; D. Allis, Mol Cell, 2018 02 01, 69, 3, p.533, (2018) PubMed

How Biophysical Forces Regulate Human B Cell Lymphomas., F. Apoorva; A.M. Loiben; S.B. Shah; A. Purwada; L. Fontan; R. Goldstein; B.J. Kirby; A.M. Melnick; B.D. Cosgrove; A. Singh, Cell Rep, 2018 Apr 10, 23, 2, p.499-511, (2018) PubMed